Man Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Man Group’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-813	Closed	-$11K	–	2295
2022 Q3	$11K	Buy	+813	New	+$23.8K	﹤0.01%	1975

Other funds holding NEXI

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Man Group's NEXI Position: Q4 2022 in Review

Man Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2022, closing a stake of 813 shares — an estimated $11K sold.

Man Group first reported a position in NEXI in Q3 2022 and held it in 1 quarter. The position peaked at $11K in Q3 2022. 29 funds tracked by Wall St. Rank hold NEXI as of Q4 2022.

Man Group reported no remaining NexImmune, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Man Group sold 813 NexImmune, Inc. Common Stock shares in Q4 2022, an estimated $11K.
Man Group first reported a position in NexImmune, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Man Group's NexImmune, Inc. Common Stock position peaked at $11K in Q3 2022.
29 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.